Regeneron Pharmaceuticals dividend and valuation

REGN · NASDAQ · USD

Compare Regeneron Pharmaceuticals
$955.47Change from previous close: +0.45%Absolute change: +$4.28

Close · November 13, 2026

Valuation

Regeneron Pharmaceuticals paid $3.70 per share in dividends over the last 12 months (yield 0.4%). Next ex-dividend date: November 20, 2026. The P/E ratio is 21.1. The average price target of 27 analysts is $984.96.

Data as of November 16, 2026

Regeneron Pharmaceuticals compared with similar companies

Regeneron Pharmaceuticals's P/E (trailing 12 months): 21.1, −39% against the median of a group of 7 similar companies (34.7).

Regeneron Pharmaceuticals's metrics compared with similar companies
MetricRegeneron PharmaceuticalsMedian25th–75th percentileBand
P/E (trailing 12 months)21.134.727.2 – 49.4Low
Forward P/E13.521.113.9 – 31.3Low
EV/EBITDA15.822.817.1 – 26.3Low
Price/book2.867.205.33 – 14.4Low
Price/sales5.8510.46.19 – 16.9Low
Gross margin46.7%56.0%23.4% – 80.8%Middle
Operating margin30.4%19.5%-61.2% – 32.1%Middle
Net margin28.5%13.9%0.0% – 29.6%Middle
ROE14.9%12.1%-21.5% – 19.6%Middle
Debt/equity0.080.350.05 – 0.73Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Regeneron Pharmaceuticals: valuation over time

On the latest fiscal year's earnings (2025), Regeneron Pharmaceuticals's P/E today is 23.0, above the median of its last 10 fiscal years (18.7; between 8.77 and 47.7 from 2016 to 2025). Relative to earnings, the stock costs more than it used to.

Regeneron Pharmaceuticals P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
2025$771.87$41.4818.6$3.520.5%
2024$712.33$38.3418.6——
2023$878.29$34.7725.3——
2022$721.49$38.2218.9——
2021$631.52$71.978.77——
2020$483.11$30.5215.8——
2019$375.48$18.4620.3——
2018$373.50$21.2917.5——
2017$375.96$10.3436.4——
2016$367.09$7.7047.7——

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$98.84B
Enterprise value
$89.29B
PEG
1.16
EV/revenue
5.28

Profitability and growth

ROA
7.6%
ROIC
16.3%
Revenue growth (year over year)
36.3%
Earnings growth (year over year)
35.5%

Financial health

Total cash
$9.3B
Total debt
$2.71B
Current ratio
3.35
Quick ratio
2.72
Altman Z-Score
6.44
Piotroski F-Score
6.00

Dividends

Annual dividend per share
$3.70
Dividend yield
0.4%
Payout ratio
8.2%
Ex-dividend date
November 20, 2026

Analysts and estimates

Average price target
$984.96
Median price target
$997.00
High price target
$1,175.00
Low price target
$812.00
Analysts with a price target
27
Consensus
Buy
Forward EPS
$70.84
EPS estimate, current year
$69.01

Shares and trading

Beta
0.10
Average volume
797.86K
Shares outstanding
101.63M
Float
96.35M
Institutional ownership
92.6%
Insider ownership
2.2%
Short interest (% of float)
2.3%
Short ratio (days)
2.93